Skip to main content
Log in

Apoptin NLS2 homodimerization strategy for improved antibacterial activity and bio-stability

  • Original Article
  • Published:
Amino Acids Aims and scope Submit manuscript

Abstract

The emergence of antibiotic resistance prompts exploration of viable antimicrobial peptides (AMPs) designs. The present study explores the antimicrobial prospects of Apoptin nuclear localization sequence (NLS2)-derived peptide ANLP (PRPRTAKRRIRL). Further, we examined the utility of the NLS dimerization strategy for improvement in antimicrobial activity and sustained bio-stability of AMPs. Initially, the antimicrobial potential of ANLP using antimicrobial peptide databases was analyzed. Then, ANLP along with its two homodimer variants namely ANLP-K1 and ANLP-K2 were synthesized and evaluated for antimicrobial activity against Escherichia coli and Salmonella. Among three AMPs, ANLP-K2 showed efficient antibacterial activity with 12 µM minimum inhibitory concentration (MIC). Slow degradation of ANLP-K1 (26.48%) and ANLP-K2 (13.21%) compared with linear ANLP (52.33%) at 480 min in serum stability assay indicates improved bio-stability of dimeric peptides. The AMPs presented no cytotoxicity in Vero cells. Dye penetration assays confirmed the membrane interacting nature of AMPs. The zeta potential analysis reveals effective charge neutralization of both lipopolysaccharide (LPS) and bacterial cells by dimeric AMPs. The dimeric AMPs on scanning electron microscopy studies showed multiple pore formations on the bacterial surface. Collectively, proposed Lysine scaffold dimerization of Apoptin NLS2 strategy resulted in enhancing antibacterial activity, bio-stability, and could be effective in neutralizing the off-target effect of LPS. In conclusion, these results suggest that nuclear localization sequence with a modified dimeric approach could represent a rich source of template for designing future antimicrobial peptides.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The experimental data generated during the present study is available from the corresponding author on reasonable request.

References

Download references

Acknowledgements

The authors are thankful to the Department of Biotechnology, Government of India for funding the research project “Development of Antimicrobial Peptide Drug Designs: An: Alternative Therapeutic Model for Salmonella BT/PR/7084/ADV/90/263/2017”. The authors are also thankful to Dr. Vijay Jadhav, Associate professor, Department of Veterinary Public Health and Epidemiology, LUVAS for providing technical help in HPLC experiments.

Funding

The study was supported by the grant provided by the Department of Biotechnology (DBT), Government of India, New Delhi “Development of Antimicrobial Peptide Drug Designs: An: Alternative Therapeutic Model for Salmonella BT/PR/7084/ADV/90/263/2017”.

Author information

Authors and Affiliations

Authors

Contributions

VJ, MS, and NJ conceived and designed the research. AK, MS, RS, VJ, and TG conducted the experiments. VJ and MS supervised the experiments. VJ, MS, AK, NJ, and TG analyzed the data. VJ, AK, MS, and SM wrote the manuscript. All the authors read and approved the manuscript.

Corresponding author

Correspondence to Vinay G. Joshi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethical permission was approved from Institutional animal ethic committee (IAEC), LUVAS, Hisar for the experiment, agenda number 6 dated 25/1/22.

Additional information

Handling editor: M. Patrick.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 655 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kumari, A., Singh, M., Sharma, R. et al. Apoptin NLS2 homodimerization strategy for improved antibacterial activity and bio-stability. Amino Acids 55, 1405–1416 (2023). https://doi.org/10.1007/s00726-023-03321-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-023-03321-1

Keywords

Navigation